United Therapeutics sell Wells Fargo & Company
Start price
20.10.25
/
50%
€372.40
Target price
20.10.26
€355.05
Performance (%)
20.27%
Price
18.08.26
€447.90
Summary
This prediction is currently active. The SELL prediction by Wells_Fargo___Compan currently has a performance of 20.27%. This prediction currently runs until 20.10.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 0.359% | 0.359% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $414.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€314.10
20.08.24
20.08.24
€341.89
20.08.25
20.08.25
-16.84%
21.08.25
21.08.25
United Therapeutics
Start price
Target price
Perf. (%)
€255.70
12.06.24
12.06.24
€323.16
12.06.25
12.06.25
-3.13%
13.06.25
13.06.25
United Therapeutics
Start price
Target price
Perf. (%)
€220.00
07.03.24
07.03.24
€298.84
07.03.25
07.03.25
32.32%
08.03.25
08.03.25
United Therapeutics
Start price
Target price
Perf. (%)
€224.60
08.12.23
08.12.23
€287.40
08.12.24
08.12.24
56.99%
09.12.24
09.12.24